Study Results Demonstrate Greater Potential of New Diabetes Therapy Beyond Glucose Control
Meta-Analysis Presented at the CDA/CSEM Professional Conference and Annual Meetings Provides Insight into GLP-1 Therapy Advances
MISSISSAUGA, ON, Nov. 8 /PRNewswire/ -
To view this Social Media Release, please enter the following address in your web browser.
SOURCE Novo Nordisk Canada Inc.